Vice President Joshua White Outlines Critical Considerations for Pharmaceutical Industry Mergers at Concurrences Event

July 11, 2023

Vice President Joshua White provided an overview of the pharmaceutical market and key factors for merger reviews during the “Mergers in the Pharmaceutical Industry” panel at the Concurrences International Mergers Conference. Mr. White outlined the structure of the market and explored features such as the complexities associated with market definition for horizontal mergers and best practices for evaluating theories of harm. He also addressed the questions of over-enforcement in the pharmaceutical industry, in which innovation has a significant impact on public health, and of pricing regulations in the UK, including concerns around high drug prices for innovations such as personalized medicine and gene therapy. Mr. White’s co-panelists explored topics such as recent mergers and trends in merger enforcement worldwide.

Read the key takeaways